Commentary

Podcast

Pharmacy Focus: Oncology Edition - PARP Inhibitors in Ovarian Cancer

Kirollos Hanna, PharmD, BCPS, BCOP, discussed how PARP inhibitors have changed the treatment landscape of ovarian cancer.

In the second episode of Pharmacy Focus: Oncology Edition, Kirollos Hanna, PharmD, BCPS, BCOP, discussed how PARP inhibitors have changed the treatment landscape of ovarian cancer.

Related Videos
Related Content
EGFR inhibited by targeted therapy | Image Credit: © patsuda - stock.adobe.com
February 24th 2025

Tanshinlactone May Inhibit the Growth of ER+, HER2+, or EGFR-Mutated Cells in Breast Cancer

Alexandra Gerlach, Associate Editor
The AQUILA Debate: Daratumumab for Treatment of Smoldering Multiple Myeloma
January 31st 2025

The AQUILA Debate: Daratumumab for Treatment of Smoldering Multiple Myeloma

Alexandra Gerlach, Associate Editor
Key Sessions and Opportunities for Pharmacists at the AACR Immunotherapy Conference
February 21st 2025

Key Sessions and Opportunities for Pharmacists at the AACR Immunotherapy Conference

Alana Hippensteele, Lead Editor
Pharmacy Focus: GLP-1 Medications and Pharmacists' Role in Counseling Patients
January 31st 2025

Pharmacy Focus: GLP-1 Medications and Pharmacists' Role in Counseling Patients

Luke Halpern, Assistant Editor
Chronic graft-vs-host disease -- Image credit: dizain | stock.adobe.com
February 21st 2025

New Therapy for Chronic Graft-Vs-Host Disease: Axatilimab

Grashma Vadakkel, PharmD, BCOP Melinda Cook, PharmD, BCOP Kristian Casem, PharmD, BCOP Stephen Eng, PharmD, BCOP
A urologist sees male patients. They specialize in men's health issues, including prostate problems - Image credit: ImageKing | stock.adobe.com
February 20th 2025

FDA Grants Fast Track Designation to 67Cu-SAR-bisPSMA for Prostate Cancer

Kennedy Ferruggia, Assistant Editor